Chemours released its 2025 Sustainability Report, highlighting an 80% reduction in fluorinated organic compound emissions since 2018 and a 57% drop in production greenhouse gases toward 2030 targets.
Bladen County secures $26.6 million from DuPont and Chemours to upgrade water infrastructure following a PFAS pollution settlement tied to their Fayetteville Works plant, part of a larger $590 million
Chemours reported mixed Q2 results with trimmed net losses and improved cash flow despite flat net sales due to volume declines. Future performance hinges on pricing gains offsetting shrinking demand
Chemours has reached a nearly $600 million settlement with North Carolina to provide clean drinking water for PFAS contamination. Backed by DuPont, the agreement ensures funds for local governments de
A federal judge ruled Chemours liable for illegally dumping forever chemicals into the Cape Fear River since 1980, impacting over 180,000 residents. A jury trial is set for next March to determine com
Chemours released its 2025 Sustainability Report, highlighting an 80% reduction in fluorinated organic chemical emissions and a 57% cut in greenhouse gases since 2018. The company also reported zero m
Zacks Research downgraded Chemours to 'Strong Sell' following missed quarterly earnings estimates for EPS and revenue. Analyst consensus remains Hold with a $21 price target despite the recent downgra
Chemours Co CFO Shane Hostetter bought 3,350 shares at $14.94, boosting direct ownership to over 102,000 shares. This transaction signals insider confidence while the stock remains modestly undervalue
Chemours Co CFO Shane Hostetter acquired 3,350 shares at $14.94 per share on August 6, increasing his beneficial ownership to 102,697 shares.
Analysts reduced Chemours' 12-month price target to $22.5 from $22.8, maintaining a consensus Buy rating from 11 analysts.
Chemours Co trades ex-dividend with a 2.2% yield, but analysts warn of risks due to last year's loss and declining five-year earnings. Despite free cash flow coverage, dividend sustainability remains
Chemours Q2 sales fell 1% to $1.591 billion amid lower Opteon refrigerant demand, though adjusted net profit reached $64 million meeting analyst expectations with free cash flow up 128%.
First Trust Advisors LP reduced its Chemours stake by 45.7% after the company missed Q2 earnings, causing an 18.3% stock drop. Analysts retain a Moderate Buy rating despite litigation costs.
Analysts lowered Chemours' 12-month price target to $24.9, implying 39% upside from current prices. The consensus rating remains 'Buy' despite the slight reduction.
Chemours maintained its 2026 outlook despite lower aftermarket refrigerant sales, reporting flat Q2 net sales of $1.591 billion. Adjusted EBITDA in its Thermal & Specialized Solutions segment rose 3%,
Chemours shares dropped 13% following a narrower loss and weak Q3 outlook driven by refrigerant demand weakness. Management anticipates titanium dioxide pricing improvements to mitigate ongoing litiga
Chemours anticipates improved Q2 earnings with $1.66 billion revenue, while investors monitor the impact of its $450 million PFAS settlement and titanium dioxide trends. Despite a Buy rating, analysts
North Carolina officials oppose a $450 million EPA settlement with Chemours over PFAS pollution in the Cape Fear River. Leaders demand a fairer deal addressing cleanup needs and resident benefits.
North Carolina officials criticize a $450 million EPA-Chemours PFAS settlement, claiming it excludes state input and inadequately addresses local damage. They urge the federal government to withdraw t
North Carolina officials oppose a federal settlement with Chemours, claiming it inadequately addresses PFAS pollution and allows the company to evade accountability. They have filed supporting documen
Chemours Co maintains a 'Hold' rating from analysts, with a top price target of $25 implying 45% upside potential. The company demonstrates stable fundamentals and high institutional ownership despite
Over 2,600 North Carolina residents settled with Chemours and DuPont over PFAS groundwater contamination from the 1980s. Broader litigation and filtration issues remain unresolved in the region.
A federal settlement imposes strict oversight and a $22.5 million penalty on Chemours' Fayetteville Works plant to address PFAS contamination. While national funding exceeds $450 million, local offici
Chemours received broker upgrades and a Zacks Rank #1 status driven by stronger earnings growth forecasts through 2026. Investors must weigh this sentiment against significant environmental risks, inc
A proposed federal settlement regarding Chemours' Fayetteville Works plant has raised local concerns over PFAS contamination and water quality funding. While pollution controls are included, direct fi
Over 2,600 residents settled a PFAS contamination lawsuit against Chemours and DuPont regarding groundwater pollution dating back to the 1980s. The agreement precedes a key trial, though maintenance d
Chemours stock has declined recently despite year-to-date gains, with analysts valuing shares at $30 against a current price of $18.24. The company faces headwinds from PFAS litigation and competition
Chemours agreed to a $450 million settlement with federal and state agencies over PFAS river contamination, despite criticism that the deal allows continued manufacturing of the chemicals.
A North Carolina plaintiff waited eight years for a PFAS trial against Chemours and DuPont, only to learn the case involving 2,658 plaintiffs over Fayetteville Works plant contamination was settled ou
Chemours shares have surged 51% year-to-date yet remain undervalued with a 0.5x price-to-sales ratio compared to the industry average of 1.1x, despite uncertainties regarding environmental and regulat
Chemours Co reached an out-of-court settlement with over 2,600 residents regarding water and land contamination near Fayetteville, resolving a significant multi-year legal battle.
Chemours has settled a lawsuit with over 2,600 plaintiffs regarding PFAS contamination in the Cape Fear River. This agreement follows a prior $450 million EPA settlement concerning environmental viola
Chemours updates investors on its strategy amid shifting specialty chemicals demand, prioritizing balance sheet discipline and high-growth fluoromaterials for semiconductors. Its stock performance tra
NC officials and environmental groups criticized an EPA settlement with Chemours over PFAS pollution, labeling it a backroom deal despite the company's $450 million pledge. They argue the state was ex
Chemours agreed to a $112.5 million settlement with US regulators regarding PFAS discharges, including penalties and mitigation projects. Investors are advised to evaluate the impact on long-term envi
Chemours agreed to a $450 million federal settlement to address PFAS contamination at four facilities, including one in South Jersey. The deal includes penalties and funding for clean drinking water f
Chemours Company (CC) released latest SEC filings detailing financial metrics and stock performance. Shares dropped 5.61% to close at $19.01, accompanied by an earnings surprise for the last quarter.
Chemours settled for $450 million to address PFAS contamination at three US facilities, including civil penalties and funding for clean water projects. The agreement permits continued PFAS production
Chemours finalized a $112.5 million PFAS settlement to clarify long-term liabilities and improve earnings visibility. Although its stock rose 64% year-to-date, analysts maintain it is undervalued with
Chemours faces a proposed federal settlement requiring $22.5 million in penalties and $90 million for PFAS mitigation following violations at its Washington Works plant. The agreement includes an $11.
Financial data displays the forward price-to-sales ratio for Chemours Co. (FWB:2CU) on the Frankfurt Stock Exchange, providing a snapshot of the chemical company's valuation metrics.
The Chemours Company (CC) financial page details stock performance, key metrics, and analyst recommendations. It highlights market capitalization, income, sales, and dividend information across variou
Chemours reached a $450 million settlement with US authorities regarding PFAS discharges, including a $22.5 million penalty and funding for emission reduction projects over 15 years. This resolves lon
Chemours Co. reached a $452.5 million federal settlement regarding unlawful PFAS discharges across three states. The deal includes a $22.5 million penalty and funding for water cleanup, though critici
North Carolina stakeholders criticize a $450 million EPA-Chemours settlement for neglecting local water contamination issues. While funds address chemical discharge elsewhere, direct aid for the pollu
Chemours agreed to a $450M settlement with U.S. regulators over PFAS discharges, covering penalties, pollution controls, and water fund contributions following a prior court order.
Chemours agreed to a $450 million settlement to reduce forever chemical pollution at its Ohio plant, paying a $22.5 million fine. Conflicts remain likely over future water discharge permits and potent
North Carolina officials criticize Chemours' $450 million PFAS settlement, claiming it offers little state benefit. Advocates demand Chemours and DuPont fund direct community cleanup instead of relyin
Chemours faces a proposed $22.5 million civil penalty for PFAS discharges, allocating $11.25 million to West Virginia. The settlement requires up to $90 million over 15 years for mitigation and water
Chemours settled with the U.S. EPA and WVDEP over PFAS discharge claims, agreeing to a $22.5 million penalty and $90 million in mitigation projects to reduce fluorinated chemical emissions by 99% by 2
ChemBrief